The treatment of asthma in adults using <font color="red">sodium_2</font> <font color="red">cromoglycate_2</font> <font color="red">pressurized_2</font> <font color="red">aerosol_2</font> <font color="red">:_2</font> a double - blind controlled trial . 
<br>
<br> <font color="red">Sodium_2</font> <font color="red">cromoglycate_2</font> <font color="red">formulated_2</font> <font color="red">as_2</font> <font color="red">a_2</font> <font color="red">pressurized_2</font> <font color="red">aerosol_2</font> ( 2 mg 4-times daily ) and <font color="red">placebo_2</font> were compared in 31 adult asthmatic patients in a double - blind crossover trial lasting 12 weeks . <font color="red">Sodium_2</font> <font color="red">cromoglycate_2</font> was superior to <font color="red">placebo_2</font> in improving breathlessness at rest ( p less than 0.001 ) , breathlessness on exertion ( p less than 0.05 ) and the quality of sleep ( p less than 0.001 ) , and also in improving the morning peak expiratory flow rate value ( p less than 0.05 ) . Both the patients ' ( p less than 0.05 ) and the clinicians ' ( p less than 0.01 ) treatment opinions , and their treatment preferences ( p less than 0.05 ) , favoured <font color="red">sodium_2</font> <font color="red">cromoglycate_2</font> <font color="red">._2</font> Moreover , usage of bronchodilators ( theophylline and aerosol beta - stimulants combined ) declined significantly ( p less than 0.001 ) during <font color="red">sodium_2</font> <font color="red">cromoglycate_2</font> <font color="red">treatment_2</font> compared to <font color="red">placebo_2</font> <font color="red">._2</font> No side - effects were reported . The results of this study show that <font color="red">sodium_2</font> <font color="red">cromoglycate_2</font> <font color="red">delivered_1</font> <font color="red">by_1</font> <font color="red">pressurized_1</font> <font color="red">aerosol_1</font> was significantly superior to <font color="red">placebo_2</font> <font color="red">,_2</font> not only in improving asthmatic symptoms , but also in reducing the amount of concomitant bronchodilator therapy required .